Zimmer Biomet Holdings, Inc. (ZBH): Price and Financial Metrics

Zimmer Biomet Holdings, Inc. (ZBH)

Today's Latest Price: $104.30 USD

6.36 (6.49%)

Updated Apr 7 10:39am

Add ZBH to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

ZBH Stock Summary

  • ZBH has a market capitalization of $19,278,100,536 -- more than approximately 92.92% of US stocks.
  • ZBH's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.28 -- higher than merely 5.14% of US-listed equities with positive expected earnings growth.
  • In terms of twelve month growth in earnings before interest and taxes, Zimmer Biomet Holdings Inc is reporting a growth rate of 6,090.16%; that's higher than 99.82% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Zimmer Biomet Holdings Inc, a group of peers worth examining would be DRAD, SD, CREG, CCCL, and BVN.
  • Visit ZBH's SEC page to see the company's official filings. To visit the company's web site, go to www.zimmerbiomet.com.
ZBH Daily Price Range
ZBH 52-Week Price Range

ZBH Stock Price Chart More Charts

ZBH Price/Volume Stats

Current price $104.30 52-week high $161.11
Prev. close $97.94 52-week low $74.37
Day low $102.00 Volume 777,272
Day high $108.45 Avg. volume 1,695,257
50-day MA $126.34 Dividend yield 0.98%
200-day MA $135.22 Market Cap 21.53B

Zimmer Biomet Holdings, Inc. (ZBH) Company Bio

Zimmer Biomet Holdings designs, develops, manufactures, and markets orthopaedic reconstructive devices, spinal and trauma devices, biologics, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific. The company was founded in 1927 and is based in Warsaw, Indiana.

ZBH Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:

We started the process of determining a valid price forecast for Zimmer Biomet Holdings Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Zimmer Biomet Holdings Inc ranked in the 26th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Zimmer Biomet Holdings Inc, consider:

  • As a business, ZBH is generating more cash flow than 79.44% of positive cash flow stocks in the Healthcare.
  • Zimmer Biomet Holdings Inc's weighted average cost of capital (WACC) is 7%; for context, that number is higher than merely 21.97% of tickers in our DCF set.
  • Zimmer Biomet Holdings Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Zimmer Biomet Holdings Inc? See ABT, BIO, ENZ, LHCG, and WST.

ZBH Latest News Stream

Event/TimeNews Detail
Loading, please wait...

ZBH Latest Social Stream

Loading social stream, please wait...

View Full ZBH Social Stream

ZBH Price Returns

1-mo -15.75%
3-mo -30.10%
6-mo -21.89%
1-year -18.35%
3-year -10.85%
5-year -7.25%
YTD -30.14%
2019 45.37%
2018 -13.30%
2017 17.86%
2016 1.46%
2015 -8.80%

ZBH Dividends

Ex-Dividend DateTypePayout AmountChange
Loading, please wait...
View Full ZBH Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.9069 seconds.